Want to join the conversation?
$ENTA announced data showing patients with genotype 1 chronic HCV infection who received recommended regimen of $ABBV's VIEKIRAX EXVIERA achieved high sustained virologic response rates at 48 weeks post-treatment. $ENTA's lead protease inhibitor, Paritaprevir, is one of the direct-acting antivirals in the VIEKIRAX EXVIERA treatment regimen.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.